SynerGene Therapeutics, Inc. — Form D
SynerGene Therapeutics, Inc. of POTOMAC, MD, a company, filed a Form D exempt-offering notice with the SEC on 2014-04-02. The offering totals $3.0M, of which $2.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-04-02
- Form: D
- Accession: 0001091006-14-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $2.4M
- Remaining: $619K
- Minimum investment: $10K
- Investors: 38
- Date of first sale: 2014-03-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-214732
Issuer
- Name: SynerGene Therapeutics, Inc.
- CIK: 0001091006
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 9812 FALLS ROAD, POTOMAC, MD, 20854
- Phone: 301-299-3224
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Maria Malena Ruiz | Executive Officer | Potomac, MD |
| Raj Shah | Director | Burlingame, CA |
| Samuel Chang | Director | Potomac, MD |
| James Hsu | Director | Potomac, MD |
| Maria Magdalena Ruiz | Executive Officer | POTOMAC, MD |
Other filings by this issuer (5)
More